Page last updated: 2024-10-15

2-keto-4-methylvalerate and Cushing Syndrome

2-keto-4-methylvalerate has been researched along with Cushing Syndrome in 1 studies

alpha-ketoisocaproic acid: RN given refers to parent cpd
4-methyl-2-oxopentanoate : A 2-oxo monocarboxylic acid anion that is the conjugate base of 4-methyl-2-oxopentanoic acid.
4-methyl-2-oxopentanoic acid : A 2-oxo monocarboxylic acid that is pentanoic acid (valeric acid) substituted with a keto group at C-2 and a methyl group at C-4. A metabolite that has been found to accumulate in maple syrup urine disease.

Cushing Syndrome: A condition caused by prolonged exposure to excess levels of cortisol (HYDROCORTISONE) or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tessari, P1
Inchiostro, S1
Biolo, G1
Marescotti, MC1
Fantin, G1
Boscarato, MT1
Merola, G1
Mantero, F1
Tiengo, A1

Other Studies

1 other study available for 2-keto-4-methylvalerate and Cushing Syndrome

ArticleYear
Leucine kinetics and the effects of hyperinsulinemia in patients with Cushing's syndrome.
    The Journal of clinical endocrinology and metabolism, 1989, Volume: 68, Issue:2

    Topics: Adolescent; Adult; Amino Acids; Blood Glucose; Cushing Syndrome; Female; Humans; Insulin; Insulin Re

1989